After the "black start" in the first week of 2024, the three major A-share indices continued to decline. On January 8, the three major indexes all fell by more than 1%, the Shanghai Composite Index fell below 2,900 points, and nearly 4,900 stocks had a trading volume of less than 700 billionInvestors are not interested in the performance. At the same time,Many ** managers are actively rebalancing and swapping shares. Recently, with the successive disclosure of announcements such as repurchases, restructurings, and private placements of listed companiesQiu Dongrong, Ge Lan, Zhu Shaoxing, Xie Zhiyu, Fu Pengbo, Fu Youxing and other well-known ** managers have also surfaced. At the same time, there are a number of equity classes in the near future** to release purchase restrictions. So, what are the managers' holdings?What are the main investment lines in 2024?**What's going on with the release of purchase restrictions?Let's listen to Xiao Miao's decomposition below.
The three major tracks were added, and the position adjustment trend of the top ** manager was announced
*From the Internet) The 2023 public offering ** manager championship battle has come to an end, and the 2024 ** ranking curtain is slowly opening. Recently, some ** managers have begun to take action and actively carry out position adjustment and share swap operations to lay out the layout for the new year's investment. SomeThe information of the top ten shareholders of tradable shares disclosed in the announcement of the listed company has unveiled the position adjustment actions of the top managers. The top ten circulating shareholders announced by Zhenjiang on January 3 are now a number of well-known managers to manage the products. As of December 27, 2023, there are the top ten circulating shareholders of Zhenjiang sharesXie Zhiyu participated in the management of Xingquan Herun and Xingquan Heyi, Zhonggeng Small Cap Value managed by Qiu Dongrong, and HSBC Jinxin Core Growth managed by Lu BinComparing the data at the end of the third quarter of 2023, it is found that Zhonggeng small-cap value ** the company's shares, while HSBC Jinxin Core Growth will newly enter its top ten outstanding shareholders in the fourth quarter of 2023. 
The top 10 outstanding shares of Zhenjiang shares, data**: wind.
Zhenjiang Co., Ltd. is a listed company in the new energy track, is a domestic enterprise specializing in new energy power generation equipment steel structure parts, the company's main business is wind power equipment, photovoltaic solar thermal equipment parts;Design, processing and sales of fasteners;Offshore wind power installation and operation and maintenance services. In terms of performance,Zhenjiang Co., Ltd. achieved operating income of 27 in the first three quarters of 20231.7 billion yuan, a year-on-year increase of 3575%；Net profit attributable to the parent company was 12.7 billion yuan, a year-on-year increase of doubled, and the performance was outstanding. The list of the top 10 circulating shareholders of pharmaceutical stocks Yaokang Biotech is now availableGülen's figure, Gülen's management of CEIBS Healthcare entered its list of top 10 circulating shareholders in the fourth quarter of 2023As of December 26, 2023, CEIBS Healthcare held 1,175660,000 shares, making it the fourth largest shareholder of the company, with a share ratio of 582%。
Top 10 Outstanding Shares of Yaokang Biotech, Data**: Wind.
Similarly, the Golden Mile Medical in the medical field recently announced thatFuguo Tianhui managed by Zhu Shaoxing, Bank of Communications New Growth managed by Wang Chong, and Huitianfu Innovative Pharmaceutical managed by Zheng Lei all appeared in its top 10 list of circulating shareholders. As of December 18, 2023, the above three ** respectively hold Jinyu Medical 1200270,000 shares, 1123470,000 shares, 954410,000 shares, compared to the number of shares held at the end of the third quarter of 2023Zhu Shaoxing increased his holdings in Jinyu Medical by 50030,000 shares, Wang Chong and Zheng Lei respectively ** Jinyu Medical 43560,000 shares, 48560,000 shares. 
Top 10 Outstanding Shares of Jinyu Medical, Data**: Wind.
Zhonggeng small-cap value managed by Qiu Dongrong increased its holdings in Yongguan New Materials after reducing its position in Zhenjiang shares, increasing its holdings by a total of 329010,000 shares, becoming the company's third largest shareholder, with a share ratio of 241%。Yongguan New Materials is a comprehensive adhesive material manufacturer, the main products include cloth tape, masking tape, PVC tape, OPP tape, double-sided tape, degradable environmental protection tape, automotive wiring harness tape, advertising consumables, etc., which are widely used in civil and industrial use, suitable for express delivery, office supplies, daily DIY, building decoration, packaging, stationery, automobile manufacturing and beauty, electronic appliances, aviation, ships, high-speed rail and other scenarios. In terms of performance, Yongguan New Materials achieved operating income of 40 in the first three quarters of 20233.3 billion yuan, a year-on-year increase of 782%；Net profit attributable to the parent company was 4883810,000 yuan, a year-on-year decrease of 795%。Currently, it has a dynamic P/E ratio of 738 times, slightly on the high side. 
Yongguan New Material's top 10 outstanding shares, data**: wind.
In addition,Fu Pengboand other management of Ruiyuan Growth Value newly entered the top ten circulating shareholders of Dongshan Precision, and the latest number of shares held is 1529550,000 shares;GF managed by Fu Youxing increased its holdings in Guizhou Tire by 739990,000 shares. Ge WeidongSugon, the "favorite", announced in early December that Ge Guilian, a member of Ge Weidong's family, had newly entered the leading company in China's supercomputing industry, 969690,000 shares, and the company has often received large sums of money from himself and his relatives in recent years. From the above position adjustment of Zhu Shaoxing, Ge Lan, Ge Weidong and other bigwigs, it can be found that the ** manager has increasedIncrease positions in new energy, medicine, artificial intelligence and other tracks that are obviously over-falling. So, what is the matter with the release of the upper limit of equity subscription by ** company?
Equity ** release of purchase restrictions, public offering against the trend
*Originated from the Internet).
In addition to actively adjusting positions and swapping shares to grasp the structural **, entering 2024, there are also many ** products that have been released from purchase restrictions. On January 2, the "veteran" Zeng Guofu managedAccording to the announcement of the Xinao Growth Select Mix, the ** has cancelled the large-amount subscription limit of 5 million yuan since September 26, 2023Resumption of large-amount subscription, transfer-in and regular fixed investment business. On the same day,Xinyuan Xinxiang flexible configuration hybrid announcement said that from now on, it will resume accepting subscriptions with a cumulative subscription amount of more than 1 million yuan for each ** account in a single day(regular fixed investment, conversion and transfer-in) business. On January 4, the Dacheng CSI 360 Internet + Big Data 100 Index announced that from January 5, 2024, the single-day single account subscription (including regular quota subscription) and the cumulative amount of conversion and transfer to the Dacheng CSI 360 Internet + Big Data 100 Index (excluding the market value of the account's stock share) will be cancelledIt should not exceed the limit of 10 million yuan (inclusive). On the same day, there were many ** similar announcements. In general, there may be a number of reasons for the relaxation of the large subscription limit:First,With the release of the 2023 annual results, the demand for performance and ranking has decreasedSecond,In 2023, the performance of some equity ** will be withdrawn, resulting in an increase in investor risk aversion and a decline in the scale. Third,**Suspend large subscriptions before dividends to avoid harming the interests of existing investors, and re-relax restrictions after dividends. At present, the valuation of major market indices is in a historical position, and industry insiders believe thatSome of the most liberalized purchase restrictions are out of optimism about the long-term trend of the market, and the release of purchase restrictions is conducive to the contrarian layout of ** managers. 
Conclusion
*Originated from the Internet).
The movement of celebrity managers has always been one of the important "weather vanes" that the market pays attention to. The recent position adjustment and stock swap of bigwigs such as Gülen and Zhu Shaoxing may be able to bring ideas to investors. In addition, Xiao Miao would like to remind the students that the 2023 annual reports of A-share listed companies have been disclosed one after another. As of January 8, more than 60 listed companies have disclosed their 2023 performance forecasts, of which more than 60% are expected to be successful. By industry, computer, communication, and other electronic equipment manufacturing companies are the most numerousStudents can pay a little attention to companies with good performance. The above analysis is for reference only and is not intended as an investment basis